These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16428540)

  • 1. The additive antinociceptive interaction between WIN 55,212-2, a cannabinoid agonist, and ketorolac.
    Ulugöl A; Ozyigit F; Yesilyurt O; Dogrul A
    Anesth Analg; 2006 Feb; 102(2):443-7. PubMed ID: 16428540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical cannabinoid enhances topical morphine antinociception.
    Yesilyurt O; Dogrul A; Gul H; Seyrek M; Kusmez O; Ozkan Y; Yildiz O
    Pain; 2003 Sep; 105(1-2):303-8. PubMed ID: 14499448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical cannabinoid antinociception: synergy with spinal sites.
    Dogrul A; Gul H; Akar A; Yildiz O; Bilgin F; Guzeldemir E
    Pain; 2003 Sep; 105(1-2):11-6. PubMed ID: 14499415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive synergy between the cannabinoid receptor agonist WIN 55,212-2 and bupivacaine in the rat formalin test.
    Kang S; Kim CH; Lee H; Kim DY; Han JI; Chung RK; Lee GY
    Anesth Analg; 2007 Mar; 104(3):719-25. PubMed ID: 17312233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pronociceptive effects of spinal dynorphin promote cannabinoid-induced pain and antinociceptive tolerance.
    Gardell LR; Burgess SE; Dogrul A; Ossipov MH; Malan TP; Lai J; Porreca F
    Pain; 2002 Jul; 98(1-2):79-88. PubMed ID: 12098619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic interaction between cannabinoid and either clonidine or neostigmine in the rat formalin test.
    Yoon MH; Choi JI
    Anesthesiology; 2003 Sep; 99(3):701-7. PubMed ID: 12960556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids blocks tactile allodynia in diabetic mice without attenuation of its antinociceptive effect.
    Doğrul A; Gül H; Yildiz O; Bilgin F; Güzeldemir ME
    Neurosci Lett; 2004 Sep; 368(1):82-6. PubMed ID: 15342139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of spinal 5-HT
    Aksu AG; Gunduz O; Ulugol A
    Can J Physiol Pharmacol; 2018 Jun; 96(6):618-623. PubMed ID: 29406831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The local antinociceptive actions of nonsteroidal antiinflammatory drugs in the mouse radiant heat tail-flick test.
    Dogrul A; Gülmez SE; Deveci MS; Gul H; Ossipov MH; Porreca F; Tulunay FC
    Anesth Analg; 2007 Apr; 104(4):927-35. PubMed ID: 17377109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide VF Enhances Cannabinoid Agonist WIN55,212-2-Induced Antinociception in Mice.
    Han ZL; Wang ZL; Li XH; Li N; Pan JX; Zheng T; Fang Q; Wang R
    Anesth Analg; 2015 Nov; 121(5):1360-8. PubMed ID: 26273748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic interaction of pregabalin with the synthetic cannabinoid WIN 55,212-2 mesylate in the hot-plate test in mice: an isobolographic analysis.
    Luszczki JJ; Florek-Łuszczki M
    Pharmacol Rep; 2012; 64(3):723-32. PubMed ID: 22814025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociceptive effect of intrathecal cannabinoid receptor agonist WIN 55,212-2 in a rat bone tumor pain model.
    Cui JH; Kim WM; Lee HG; Kim YO; Kim CM; Yoon MH
    Neurosci Lett; 2011 Apr; 493(3):67-71. PubMed ID: 21195743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential cholera-toxin sensitivity of supraspinal antinociception induced by the cannabinoid agonists delta9-THC, WIN 55,212-2 and anandamide in mice.
    Raffa RB; Stone DJ; Hipp SJ
    Neurosci Lett; 1999 Mar; 263(1):29-32. PubMed ID: 10218903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.
    Tham SM; Angus JA; Tudor EM; Wright CE
    Br J Pharmacol; 2005 Mar; 144(6):875-84. PubMed ID: 15778704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra-low dose naltrexone enhances cannabinoid-induced antinociception.
    Paquette J; Olmstead MC
    Behav Pharmacol; 2005 Dec; 16(8):597-603. PubMed ID: 16286810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rodent amygdala contributes to the production of cannabinoid-induced antinociception.
    Manning BH; Martin WJ; Meng ID
    Neuroscience; 2003; 120(4):1157-70. PubMed ID: 12927220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An examination of the central sites of action of cannabinoid-induced antinociception in the rat.
    Martin WJ; Patrick SL; Coffin PO; Tsou K; Walker JM
    Life Sci; 1995; 56(23-24):2103-9. PubMed ID: 7776838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception.
    Hasanein P; Parviz M; Keshavarz M; Javanmardi K
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):439-49. PubMed ID: 17439413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynorphin-independent spinal cannabinoid antinociception.
    Gardell LR; Ossipov MH; Vanderah TW; Lai J; Porreca F
    Pain; 2002 Dec; 100(3):243-248. PubMed ID: 12467995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic effects of amlodipine and its interaction with morphine and ketorolac-induced analgesia.
    Doğrul A; Yeşilyurt O; Deniz G; Işimer A
    Gen Pharmacol; 1997 Nov; 29(5):839-45. PubMed ID: 9347336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.